William Blair Investment Management LLC Purchases 20,829 Shares of ICU Medical, Inc. $ICUI

William Blair Investment Management LLC grew its position in ICU Medical, Inc. (NASDAQ:ICUI) by 9.9% in the 3rd quarter, according to its most recent filing with the SEC. The firm owned 232,168 shares of the medical instruments supplier’s stock after buying an additional 20,829 shares during the period. William Blair Investment Management LLC’s holdings in ICU Medical were worth $27,851,000 at the end of the most recent reporting period.

Several other large investors have also made changes to their positions in ICUI. SJS Investment Consulting Inc. boosted its holdings in ICU Medical by 41,000.0% in the third quarter. SJS Investment Consulting Inc. now owns 411 shares of the medical instruments supplier’s stock valued at $49,000 after acquiring an additional 410 shares during the last quarter. Covestor Ltd lifted its position in ICU Medical by 70.7% during the 3rd quarter. Covestor Ltd now owns 570 shares of the medical instruments supplier’s stock valued at $68,000 after purchasing an additional 236 shares during the period. Smartleaf Asset Management LLC lifted its position in ICU Medical by 11.6% during the 2nd quarter. Smartleaf Asset Management LLC now owns 969 shares of the medical instruments supplier’s stock valued at $128,000 after purchasing an additional 101 shares during the period. Headlands Technologies LLC bought a new position in shares of ICU Medical in the 2nd quarter valued at about $177,000. Finally, AlphaQuest LLC boosted its stake in shares of ICU Medical by 3,058.3% in the 2nd quarter. AlphaQuest LLC now owns 1,516 shares of the medical instruments supplier’s stock valued at $200,000 after purchasing an additional 1,468 shares during the last quarter. Institutional investors and hedge funds own 96.10% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently weighed in on the stock. Wall Street Zen raised shares of ICU Medical from a “hold” rating to a “buy” rating in a research note on Sunday, February 15th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of ICU Medical in a report on Thursday, January 22nd. Piper Sandler increased their price target on ICU Medical from $172.00 to $178.00 and gave the company an “overweight” rating in a research note on Friday, February 20th. Finally, KeyCorp raised their price target on ICU Medical from $175.00 to $180.00 and gave the stock an “overweight” rating in a research report on Friday, February 20th. One analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, ICU Medical currently has an average rating of “Moderate Buy” and a consensus target price of $179.33.

ICU Medical Stock Down 2.4%

Shares of NASDAQ:ICUI opened at $146.99 on Tuesday. The company has a 50 day moving average price of $149.92 and a two-hundred day moving average price of $137.54. The company has a debt-to-equity ratio of 0.60, a quick ratio of 1.15 and a current ratio of 2.39. The company has a market capitalization of $3.63 billion, a PE ratio of 7,353.18, a PEG ratio of 2.17 and a beta of 0.79. ICU Medical, Inc. has a 52 week low of $107.00 and a 52 week high of $160.29.

ICU Medical (NASDAQ:ICUI) last announced its quarterly earnings results on Thursday, February 19th. The medical instruments supplier reported $1.91 earnings per share for the quarter, topping analysts’ consensus estimates of $1.68 by $0.23. ICU Medical had a net margin of 0.03% and a return on equity of 7.33%. The company had revenue of $535.94 million for the quarter, compared to analysts’ expectations of $541.20 million. During the same period last year, the firm posted $2.11 earnings per share. The business’s quarterly revenue was down 14.1% compared to the same quarter last year. ICU Medical has set its FY 2026 guidance at 7.750-8.450 EPS. Analysts forecast that ICU Medical, Inc. will post 4.11 earnings per share for the current year.

ICU Medical Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.